Part VI: Metabolic Integration & Regulation

Chapter 28: Organ-Specific Metabolism

Each organ has a distinctive metabolic profile shaped by its physiological function, enzyme complement, and fuel preferences. Understanding these organ-specific metabolic signatures is essential for comprehending whole-body fuel homeostasis and the pathophysiology of metabolic diseases.

28.1 Brain Metabolism

The brain, despite comprising only about 2% of body mass, consumes approximately 20% of total body oxygen and 25% of total body glucose at rest. It is an obligate glucose consumer under normal conditions, oxidizing roughly 120 g of glucose per day. The brain lacks significant fuel stores and depends on a continuous supply from the blood.

The brain's glucose consumption rate can be expressed as:

where \(\text{CMR}_{\text{glc}}\) is the cerebral metabolic rate for glucose,\(\text{CBF}\) is cerebral blood flow, and \(C_a\) and \(C_v\) are arterial and venous glucose concentrations respectively.

During prolonged starvation (beyond 2-3 days), the brain progressively adapts to use ketone bodies, which can eventually supply up to 60-70% of the brain's energy needs. This adaptation is critical for survival, as it reduces the need for gluconeogenesis from amino acids, thereby sparing muscle protein.

28.2 Liver: The Metabolic Hub

The liver is the central metabolic organ, uniquely positioned to receive nutrient-rich blood from the portal vein after intestinal absorption. It performs an extraordinary range of metabolic functions, acting as both a metabolic processor and a buffer between dietary intake and the systemic circulation.

A critical feature of the liver is its expression of glucokinase (hexokinase IV) rather than hexokinase I-III. Glucokinase has a high \(K_m\) for glucose (~10 mM) and is not inhibited by glucose-6-phosphate, allowing the liver to phosphorylate glucose in proportion to its concentration. This makes the liver a “glucose buffer” that takes up glucose when blood levels are high and releases it when levels fall.

28.3 Skeletal Muscle

Skeletal muscle constitutes approximately 40% of body mass and is the largest consumer of metabolic fuels during physical activity. At rest, muscle primarily oxidizes fatty acids (approximately 85% of energy), but during intense exercise, it shifts dramatically to glucose and glycogen utilization.

Muscle glycogen stores (~400 g in a 70 kg person) serve as a local fuel reserve. Unlike the liver, muscle lacks glucose-6-phosphatase and therefore cannot release free glucose into the blood. Muscle glycogen is used exclusively for local energy needs.

Muscle is also a major site of branched-chain amino acid (BCAA) catabolism, containing high levels of BCAA transaminase. The resulting branched-chain keto acids can be oxidized locally or exported to the liver. The amino group is transferred to pyruvate to form alanine, which is exported to the liver for gluconeogenesis (glucose-alanine cycle).

28.4 Interorgan Metabolic Cycles

28.5 Adipose Tissue

Adipose tissue is far more than a passive fat store. It is a metabolically active endocrine organ that secretes numerous signaling molecules called adipokines. Its primary metabolic functions include triacylglycerol synthesis (lipogenesis) and breakdown (lipolysis).

Hormone-sensitive lipase (HSL) is the key enzyme regulating lipolysis. It is activated by phosphorylation (via PKA, stimulated by catecholamines and glucagon) and inhibited by insulin-mediated dephosphorylation. The released fatty acids and glycerol are exported: fatty acids bind to albumin for transport to other tissues, while glycerol goes to the liver for gluconeogenesis.

Key adipokines include leptin (signals adiposity to the brain, suppresses appetite), adiponectin (enhances insulin sensitivity, promotes fatty acid oxidation), and resistin (may contribute to insulin resistance).

28.6 Heart

The heart is the most metabolically active organ per unit mass, consuming approximately 6-8 kg of ATP per day despite weighing only about 300 g. It is a metabolic omnivore with remarkable flexibility. Under normal conditions, approximately 60-70% of cardiac energy comes from fatty acid oxidation, 20-30% from glucose and lactate, and a smaller fraction from ketone bodies and amino acids.

The heart readily oxidizes lactate, making it a net consumer of blood lactate. During exercise, when blood lactate levels rise, the heart increases its lactate uptake and oxidation. In heart failure, the metabolic profile shifts toward greater glucose utilization (a fetal-like pattern), which may represent a compensatory mechanism to improve oxygen efficiency.

28.7 Kidney

The kidney plays two important metabolic roles beyond its excretory function. First, during prolonged fasting, the renal cortex becomes a significant gluconeogenic organ, contributing up to 40% of total gluconeogenesis (the remainder coming from the liver). The kidney uses glutamine as its primary gluconeogenic precursor.

Second, the kidney produces ammonia from glutamine (via glutaminase and glutamate dehydrogenase) for acid-base regulation. In metabolic acidosis, renal ammoniagenesis increases dramatically to buffer hydrogen ions:

28.8 Red Blood Cells

Mature red blood cells (erythrocytes) are unique among human cells in that they lack mitochondria, a nucleus, and other organelles. Their sole energy source is anaerobic glycolysis, producing 2 ATP and 2 lactate per glucose molecule. This lactate is exported and converted back to glucose by the liver (Cori cycle).

RBCs have a unique side pathway: the Rapoport-Luebering (bisphosphoglycerate) shunt, which produces 2,3-bisphosphoglycerate (2,3-BPG). This metabolite binds to deoxyhemoglobin and reduces its oxygen affinity, facilitating oxygen release to tissues:

28.9 Summary: Organ Fuel Preferences

Chapter 29: Hormonal Regulation of Metabolism

Metabolic pathways do not operate in isolation; they are coordinated across tissues by hormonal signals. The endocrine system acts as a metabolic communication network, ensuring that fuel storage and mobilization are matched to the body's physiological state. Insulin and glucagon are the master regulators, but catecholamines, cortisol, and thyroid hormones also play critical roles.

29.1 Insulin Signaling and Metabolic Effects

Insulin is secreted by pancreatic beta-cells in response to elevated blood glucose. Its signaling cascade begins with binding to the insulin receptor (a receptor tyrosine kinase), triggering autophosphorylation and downstream signaling:

Akt (protein kinase B) is the central effector kinase of insulin signaling, mediating most metabolic effects including GLUT4 translocation, glycogen synthase activation, and inhibition of gluconeogenic gene expression (via FOXO phosphorylation).

29.2 Glucagon Signaling and Counter-Regulation

Glucagon is secreted by pancreatic alpha-cells in response to low blood glucose, amino acids (especially during a high-protein meal), and sympathetic stimulation. Its primary targets are the liver and adipose tissue.

Glucagon signals through a G-protein-coupled receptor (GCGR), activating adenylyl cyclase to produce cyclic AMP (cAMP). The resulting signaling cascade is:

PKA phosphorylates numerous target enzymes, activating glycogen phosphorylase (via phosphorylase kinase) and inhibiting glycogen synthase. In the liver, PKA also activates the transcription factor CREB, which induces expression of gluconeogenic enzymes (PEPCK, G6Pase) and the coactivator PGC-1alpha.

29.3 Epinephrine and Norepinephrine

Catecholamines mediate the fight-or-flight metabolic response via both alpha- and beta-adrenergic receptors. Beta-adrenergic stimulation activates adenylyl cyclase (similar to glucagon), while alpha-adrenergic stimulation activates phospholipase C, generating IP3 and DAG to release intracellular calcium.

Key metabolic effects of epinephrine include: rapid glycogenolysis in both liver and muscle (glucagon only acts on liver), lipolysis in adipose tissue, increased cardiac output and blood flow to muscles, and bronchodilation to increase oxygen delivery.

29.4 Cortisol

Cortisol, the primary glucocorticoid, acts through nuclear receptors to alter gene transcription. Its metabolic effects are slower (hours) but more sustained than those of insulin or catecholamines. Cortisol promotes gluconeogenesis (inducing PEPCK, G6Pase), protein catabolism in muscle (providing amino acid substrates), and lipolysis in adipose tissue. Chronic hypercortisolism (Cushing's syndrome) causes central obesity, hyperglycemia, and muscle wasting.

29.5 Thyroid Hormones

Thyroid hormones (T3, T4) regulate the basal metabolic rate (BMR). T3 acts via nuclear receptors to increase expression of metabolic enzymes, Na+/K+-ATPase, and mitochondrial uncoupling proteins. Hyperthyroidism increases BMR by 60-100%, while hypothyroidism decreases it by 40%.

29.6 AMPK: The Cellular Energy Sensor

AMP-activated protein kinase (AMPK) acts as a cellular fuel gauge, responding to changes in the energy charge of the cell. The adenylate energy charge is defined as:

Normal energy charge is approximately 0.85-0.90. When ATP is consumed and AMP accumulates, AMPK is activated by both allosteric binding of AMP and phosphorylation by upstream kinases (LKB1, CaMKK2). Due to the adenylate kinase equilibrium (\(2\text{ADP} \rightleftharpoons \text{ATP} + \text{AMP}\)), a small decrease in ATP leads to a much larger relative increase in AMP, making AMPK an extremely sensitive sensor.

29.7 mTOR: The Growth and Nutrient Sensor

The mechanistic target of rapamycin (mTOR) integrates signals from growth factors (insulin, IGF-1), nutrient availability (amino acids, especially leucine), and energy status (via AMPK). mTOR complex 1 (mTORC1) promotes protein synthesis, lipid synthesis, and cell growth when nutrients are abundant, while being inhibited under nutrient-poor conditions.

Chapter 30: Fed & Fasting States

The human body seamlessly transitions between metabolic states depending on nutrient availability. From the well-fed state to prolonged starvation, a carefully orchestrated hormonal and enzymatic program redirects metabolic flux to maintain fuel homeostasis. This chapter traces these transitions quantitatively.

30.1 The Well-Fed (Absorptive) State

During and immediately after a meal (0-4 hours post-meal), blood glucose rises, triggering insulin secretion and suppressing glucagon. The high I/G ratio directs metabolism toward fuel storage.

In the liver: glucose is taken up via GLUT2, phosphorylated by glucokinase, and directed toward glycogenesis (up to ~100 g glycogen capacity) and, when glycogen stores are full, de novo lipogenesis. Dietary amino acids are used for protein synthesis or deaminated, with carbon skeletons feeding the TCA cycle or lipogenesis. Dietary fats are repackaged as VLDL for export.

In muscle: insulin stimulates GLUT4 translocation, increasing glucose uptake 10-20 fold. Glucose is stored as glycogen and amino acid uptake is enhanced for protein synthesis.

In adipose: insulin activates lipoprotein lipase (LPL) to extract fatty acids from circulating VLDL and chylomicrons. Glucose uptake provides glycerol-3-phosphate for triacylglycerol synthesis. Insulin inhibits HSL, suppressing lipolysis.

30.2 Early Fasting (Post-Absorptive State, 4-16 hours)

As blood glucose declines, insulin falls and glucagon rises. The primary metabolic objective is to maintain blood glucose for glucose-dependent tissues (brain, RBCs).

Hepatic glycogenolysis is the dominant glucose source in this phase, providing approximately 70% of glucose production. Gluconeogenesis from lactate (Cori cycle), alanine (glucose-alanine cycle), and glycerol (from adipose lipolysis) provides the remaining 30%. The liver contains approximately 80-100 g of glycogen, sufficient for 12-16 hours of fasting.

30.3 Intermediate Fasting (16 hours - 2 days)

As liver glycogen becomes depleted, gluconeogenesis becomes the dominant source of blood glucose. Substrates for gluconeogenesis include lactate (from RBCs, muscle), alanine (from muscle protein degradation), glycerol (from adipose lipolysis), and glutamine (from muscle).

Fatty acid oxidation increases substantially. In the liver, the increased ratio of\(\text{[Acetyl-CoA]}/\text{[CoA]}\) and \(\text{[NADH]}/\text{[NAD}^+\text{]}\) inhibits pyruvate dehydrogenase, diverting pyruvate toward gluconeogenesis. Excess acetyl-CoA from fatty acid oxidation is channeled into ketogenesis.

The Randle Cycle (Glucose-Fatty Acid Cycle)

The Randle cycle describes the reciprocal relationship between glucose and fatty acid oxidation. When fatty acid oxidation increases, the resulting elevated acetyl-CoA and citrate inhibit glycolysis, and elevated NADH inhibits the TCA cycle entry of pyruvate. Conversely, when glucose oxidation is high, malonyl-CoA (from acetyl-CoA carboxylase) inhibits CPT-1, blocking fatty acid entry into mitochondria.

30.4 Prolonged Starvation (>2 days)

During prolonged starvation, the most critical metabolic adaptation is the shift of the brain from glucose to ketone body utilization. Hepatic ketogenesis increases dramatically, and blood ketone body levels rise from \(<0.1\) mM (fed) to 6-8 mM (3+ weeks of starvation). As the brain adapts to using ketones (supplying up to 60-70% of its energy), the demand for gluconeogenesis decreases, leading to protein sparing.

30.5 Comparison of Metabolic States

30.6 Refeeding Syndrome

Chapter 31: Exercise Metabolism

Physical exercise places extraordinary demands on metabolic systems. The transition from rest to maximal exercise can increase metabolic rate 15-20 fold, requiring rapid and coordinated shifts in fuel supply. Different energy systems dominate at different exercise durations and intensities, creating a continuum of metabolic strategies.

31.1 The ATP-Phosphocreatine System (0-10 seconds)

The immediate energy system relies on pre-existing ATP stores and the phosphocreatine (PCr) buffer. Muscle ATP stores are very small (~5 mmol/kg), sufficient for only 1-2 seconds of maximal effort. The creatine kinase reaction rapidly regenerates ATP from PCr:

The equilibrium constant for creatine kinase strongly favors ATP production (\(K_{eq} \approx 1.66 \times 10^9 \text{ M}^{-1}\)), maintaining near-constant ATP levels until PCr is substantially depleted. The PCr store (~17 mmol/kg) extends maximal effort to approximately 8-10 seconds.

31.2 Anaerobic Glycolysis (10 seconds - 2 minutes)

As PCr is depleted, anaerobic glycolysis becomes the dominant ATP source for high-intensity exercise. Muscle glycogen is rapidly broken down, and pyruvate is reduced to lactate by lactate dehydrogenase (LDH) to regenerate NAD+ for continued glycolysis:

Note that glycogenolysis yields 3 ATP per glucose unit (vs. 2 from free glucose) because the phosphorolysis step bypasses the hexokinase reaction. The lactate threshold is the exercise intensity at which blood lactate begins to accumulate exponentially, typically occurring at 50-80% of \(\dot{V}\text{O}_{2\text{max}}\) depending on training status.

Contrary to a common misconception, lactate is not a metabolic waste product. It is a valuable fuel that is oxidized by the heart, slow-twitch muscle fibers, and the liver. The lactate shuttle hypothesis proposes that lactate serves as a major vehicle for distributing oxidative fuel between cells and tissues.

31.3 Aerobic Metabolism (>2 minutes)

For sustained exercise, aerobic metabolism provides the vast majority of ATP. The relative contribution of carbohydrates versus fats depends on exercise intensity, duration, training status, and nutritional state.

The Crossover Concept

The crossover concept describes the shift in substrate utilization as exercise intensity increases. At low intensities (<40% \(\dot{V}\text{O}_{2\text{max}}\)), fatty acids are the predominant fuel. As intensity increases, the relative contribution of carbohydrates increases, with a “crossover point” typically near 60-65%\(\dot{V}\text{O}_{2\text{max}}\) where carbohydrate and fat oxidation contribute equally. At near-maximal intensities, carbohydrates supply >90% of energy.

31.4 VO2max and Metabolic Capacity

\(\dot{V}\text{O}_{2\text{max}}\) represents the maximum rate of oxygen consumption during exercise, reflecting the integrated capacity of the cardiovascular and muscular systems. Typical values range from 35-45 mL/kg/min in untrained adults to 70-85 mL/kg/min in elite endurance athletes. At \(\dot{V}\text{O}_{2\text{max}}\), the total metabolic rate can reach 15-20 times the resting rate.

31.5 EPOC (Excess Post-Exercise Oxygen Consumption)

After exercise cessation, oxygen consumption remains elevated above resting levels for minutes to hours. This EPOC (formerly called “oxygen debt”) reflects several metabolic processes: replenishment of PCr and ATP stores, lactate oxidation and gluconeogenesis, repayment of the myoglobin oxygen store, elevated body temperature and heart rate, and catecholamine-mediated lipolysis.

The magnitude of EPOC depends on exercise intensity and duration. High-intensity interval training (HIIT) produces a greater EPOC than moderate-intensity continuous exercise, which partially explains its effectiveness for body composition management.

31.6 Metabolic Adaptations to Training

Chapter 32: Metabolic Disorders

Metabolic diseases arise when the regulatory mechanisms described in previous chapters fail. From the global epidemic of diabetes and obesity to rare inborn errors of metabolism, these disorders illustrate the consequences of metabolic dysregulation and highlight the clinical relevance of every pathway we have studied.

32.1 Diabetes Mellitus

Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both. It is the most common metabolic disorder worldwide, affecting over 500 million people.

Type 1 Diabetes

Type 1 diabetes results from autoimmune destruction of pancreatic beta-cells, leading to absolute insulin deficiency. Without insulin, tissues cannot take up glucose (except brain and liver, which have insulin-independent glucose transporters), and counter-regulatory hormones (glucagon, cortisol, epinephrine) are unopposed. This creates a metabolic paradox: hyperglycemia coexists with cellular glucose starvation.

Diabetic Ketoacidosis (DKA)

Type 2 Diabetes and Insulin Resistance

Type 2 diabetes is characterized by insulin resistance and progressive beta-cell dysfunction. Initially, beta-cells compensate by secreting more insulin (hyperinsulinemia), but over time, beta-cell exhaustion leads to relative insulin deficiency and overt hyperglycemia.

Molecular mechanisms of insulin resistance include: serine phosphorylation of IRS-1 (instead of the normal tyrosine phosphorylation), inflammation (TNF-alpha, IL-6 from adipose tissue), ER stress, lipotoxicity (ceramide and DAG accumulation), and mitochondrial dysfunction.

Metabolic Syndrome

Metabolic syndrome is a cluster of interrelated metabolic risk factors that increase the likelihood of type 2 diabetes and cardiovascular disease. Diagnostic criteria (3 of 5 required): waist circumference >102 cm (men) or >88 cm (women), triglycerides >150 mg/dL, HDL-cholesterol <40 mg/dL (men) or <50 mg/dL (women), blood pressure >130/85 mmHg, and fasting glucose >100 mg/dL.

HbA1c as a Metabolic Marker

Glycated hemoglobin (HbA1c) reflects average blood glucose over the preceding 2-3 months (the lifespan of red blood cells). Glucose reacts non-enzymatically with the N-terminal valine of the hemoglobin beta-chain (Amadori rearrangement). Normal HbA1c is less than 5.7%, prediabetes is 5.7-6.4%, and diabetes is 6.5% or greater. The relationship between HbA1c and mean plasma glucose is approximately:

32.2 Obesity

Obesity results from a chronic positive energy balance where energy intake exceeds expenditure. The body mass index (BMI) is used as a simple screening measure:

Classifications: normal weight (18.5-24.9), overweight (25.0-29.9), obese class I (30.0-34.9), obese class II (35.0-39.9), and obese class III (>40.0). The energy balance equation is:

where total energy expenditure = BMR (60-70%) + thermic effect of food (10%) + physical activity (20-30%). A sustained positive imbalance of just 100 kcal/day can lead to a weight gain of approximately 4.5 kg per year.

Leptin resistance is a key feature of obesity. Despite high circulating leptin levels (proportional to adipose mass), the hypothalamus fails to respond appropriately, disrupting the negative feedback loop that normally suppresses appetite and increases energy expenditure. Mechanisms include reduced leptin transport across the blood-brain barrier, impaired JAK-STAT signaling, and increased expression of SOCS3 (a negative regulator).

32.3 Inborn Errors of Metabolism

Inborn errors of metabolism are genetic disorders caused by mutations in genes encoding metabolic enzymes or transporters. While individually rare, collectively they affect approximately 1 in 1,000-2,500 live births.

32.4 Fatty Liver Disease (NAFLD/NASH)

Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive hepatic triglyceride accumulation (>5% of liver weight) in the absence of significant alcohol consumption. It affects approximately 25% of the global population and is strongly associated with obesity, insulin resistance, and metabolic syndrome.

The pathogenesis involves a “multiple-hit” model: insulin resistance drives increased hepatic lipogenesis (via SREBP-1c activation) and fatty acid uptake (from adipose lipolysis), while impaired fatty acid oxidation and VLDL export compound the fat accumulation. Progression to NASH (non-alcoholic steatohepatitis) involves oxidative stress, mitochondrial dysfunction, ER stress, and inflammatory cytokine production. NASH can progress to fibrosis, cirrhosis, and hepatocellular carcinoma.

32.5 Cancer Metabolism

Cancer cells exhibit profound metabolic reprogramming to support rapid proliferation. The most well-known alteration is the Warburg effect: cancer cells preferentially metabolize glucose to lactate even in the presence of adequate oxygen (aerobic glycolysis).

Many cancers also exhibit glutamine addiction, relying on glutamine as a carbon and nitrogen source for biosynthesis. Glutamine provides nitrogen for nucleotide and amino acid synthesis and carbon for anaplerosis (replenishing TCA cycle intermediates diverted to biosynthesis). The enzyme glutaminase is often overexpressed in tumors, and glutaminase inhibitors are under clinical investigation.

Oncogenes and tumor suppressors directly rewire metabolism: HIF-1alpha induces glycolytic enzymes and glucose transporters; c-Myc activates glutaminase and mitochondrial biogenesis; p53 promotes oxidative phosphorylation and inhibits glycolysis; PI3K/Akt/mTOR signaling drives anabolic metabolism. Understanding cancer metabolism has led to new therapeutic strategies, including PET scanning (using \(^{18}\text{F}\)-FDG to detect glucose-avid tumors) and metabolic inhibitors.

32.6 Mitochondrial Diseases

Mitochondrial diseases result from mutations in either mitochondrial DNA (mtDNA) or nuclear genes encoding mitochondrial proteins. Since mtDNA is maternally inherited, many mitochondrial diseases show a maternal inheritance pattern. A key feature is heteroplasmy: cells contain hundreds to thousands of mtDNA copies, and the proportion of mutant copies determines disease severity (threshold effect, typically 60-90% mutant load).

Clinical manifestations preferentially affect tissues with high energy demands: the nervous system (encephalopathy, seizures), skeletal muscle (myopathy, exercise intolerance), heart (cardiomyopathy), and endocrine organs. Common syndromes include MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes), MERRF (myoclonic epilepsy with ragged-red fibers), and Leber hereditary optic neuropathy (LHON).